Anti-ACSL1 Antibody

This antibody targets Long-chain-fatty-acid—CoA ligase 1 (ACSL1), a key enzyme in lipid metabolism that activates long-chain fatty acids by converting them into fatty acyl-CoA esters. ACSL1 plays a central role in regulating lipid synthesis, β-oxidation, and membrane remodeling. Its activity influences cellular energy homeostasis and lipid signaling pathways.ACSL1 is strongly associated with metabolic disorders, including insulin resistance, obesity, and type 2 diabetes, as well as cardiovascular diseases, due to its role in controlling the balance between lipid storage and degradation.Demonstrated performance in immunofluorescence, and immunohistochemistry allows this antibody to support studies of lipid metabolism, mitochondrial function, and metabolic syndrome. It is an essential reagent for research into energy metabolism, obesity, and related metabolic diseases.